Note 25 - Segment Reporting - Schedule of Segment Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Feb. 28, 2026 |
Feb. 28, 2025 |
Feb. 28, 2026 |
Feb. 28, 2025 |
|
| Net revenue | $ 206,732 | $ 185,780 | $ 633,740 | $ 596,774 |
| Cost of goods sold | 151,778 | 133,769 | 463,820 | 423,837 |
| Gross Profit | 54,954 | 52,011 | 169,920 | 172,937 |
| General and administrative | 50,228 | 39,246 | 142,456 | 129,356 |
| Selling | 10,617 | 13,905 | 35,321 | 41,757 |
| Amortization | 5,106 | 23,182 | 13,393 | 67,913 |
| Marketing and promotion | 8,692 | 6,793 | 28,828 | 28,079 |
| Research and development | 62 | 85 | 181 | 250 |
| Change in fair value of contingent consideration | 0 | 0 | (15,000) | 0 |
| Impairment of intangible assets and goodwill | 0 | 699,235 | 0 | 699,235 |
| Other than temporary change in fair value of convertible notes receivable | 0 | 20,000 | 0 | 20,000 |
| Litigation costs, net of recoveries | 621 | 2,758 | 2,497 | 5,254 |
| Restructuring costs | 4,087 | 6,133 | 5,921 | 17,249 |
| Transaction costs (income), net | 1,927 | 605 | 2,896 | 2,563 |
| Total operating expenses | 81,340 | 811,942 | 216,493 | 1,011,656 |
| Operating loss | (26,386) | (759,931) | (46,573) | (838,719) |
| Interest expense, net | (4,965) | (8,378) | (17,035) | (25,986) |
| Non-operating income (expense), net | 8,092 | (24,022) | (386) | (44,631) |
| Loss before income taxes | (23,259) | (792,331) | (63,994) | (909,336) |
| Income tax expense (recovery), net | 1,974 | 1,203 | 3,235 | 4,125 |
| Net loss | (25,233) | (793,534) | (67,229) | (913,461) |
| Cannabis Segment [Member] | ||||
| Net revenue | 64,828 | 54,274 | 196,871 | 181,175 |
| Cost of goods sold | 38,858 | 32,275 | 121,497 | 111,804 |
| Gross Profit | 25,970 | 21,999 | 75,374 | 69,371 |
| Revenue | 83,835 | 72,982 | 261,778 | 241,384 |
| Excise taxes | (19,007) | (18,708) | (64,907) | (60,209) |
| Cannabis Segment [Member] | Medical Cannabis Products [Member] | ||||
| Revenue | 5,979 | 5,839 | 18,359 | 18,773 |
| Cannabis Segment [Member] | Adult-use Cannabis Products [Member] | ||||
| Revenue | 52,570 | 49,315 | 179,085 | 165,627 |
| Cannabis Segment [Member] | Wholesale Cannabis Products [Member] | ||||
| Revenue | 1,165 | 3,893 | 6,666 | 15,993 |
| Cannabis Segment [Member] | International Cannabis Products [Member] | ||||
| Revenue | 24,121 | 13,935 | 57,668 | 40,991 |
| Beverage Alcohol Business [Member] | ||||
| Net revenue | 42,558 | 55,921 | 148,380 | 174,974 |
| Cost of goods sold | 28,977 | 35,986 | 97,741 | 106,961 |
| Gross Profit | 13,581 | 19,935 | 50,639 | 68,013 |
| Revenue | 44,524 | 58,009 | 156,588 | 184,033 |
| Excise taxes | (1,966) | (2,088) | (8,208) | (9,059) |
| Distribution Business [Member] | ||||
| Net revenue | 82,963 | 61,493 | 242,286 | 197,175 |
| Cost of goods sold | 72,951 | 55,936 | 213,293 | 175,281 |
| Gross Profit | 10,012 | 5,557 | 28,993 | 21,894 |
| Wellness Business [Member] | ||||
| Net revenue | 16,383 | 14,092 | 46,203 | 43,450 |
| Cost of goods sold | 10,992 | 9,572 | 31,289 | 29,791 |
| Gross Profit | $ 5,391 | $ 4,520 | $ 14,914 | $ 13,659 |
| X | ||||||||||
- Definition The amount of change in fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Amount of other-than-temporary fair value loss on convertible notes receivable. No definition available.
|
| X | ||||||||||
- Definition Information pertaining to (income) and expenses related to various business activities. No definition available.
|
| X | ||||||||||
- Definition The amount of amortization of deferred charges applied against earnings during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|